Detailseite
Projekt Druckansicht

Regulierung des hepatischen Glukose- und Fettstoffwechsels durch die Retinol Saturase

Fachliche Zuordnung Endokrinologie, Diabetologie, Metabolismus
Förderung Förderung von 2010 bis 2017
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 161885875
 
Erstellungsjahr 2017

Zusammenfassung der Projektergebnisse

The liver integrates multiple metabolic pathways to warrant systemic energy homeostasis. An exaggerated lipogenic flux due to chronic dietary stimulation contributes to the development of hepatic steatosis, dyslipidemia, and hyperglycemia. We identified a novel function of the oxidoreductase retinol saturase (RetSat) in metabolic liver disease. Hepatic RetSat expression correlated with steatosis and serum triglycerides in humans. Liver-specific disruption of RetSat in dietary-obese mice lowered hepatic and circulating triglycerides and normalized hyperglycemia. Mechanistically, RetSat depletion reduced the activity of carbohydrate response element-binding protein (ChREBP), a cellular hexose-phosphate sensor and inducer of de novo lipogenesis. Defects upon RetSat depletion were rescued by ectopic ChREBP but not by its putative enzymatic product 13,14-dihydroretinol, suggesting that RetSat affects hepatic glucose sensing independent of retinol conversion. In summary, we identified RetSat as critical regulator of liver metabolism that functions upstream of ChREBP. Pharmacologic inhibition of RetSat in liver may represent a therapeutic approach to metabolic liver disease.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung